InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Harsaul Foundation. Officer active across 1 company, notably RVL Pharmaceuticals plc. Cumulatively, 2 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €617k. History available since 18 October 2023. The latest transaction was disclosed on 19 October 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations